1887

Chapter 30 : Peptide Antibiotics

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Peptide Antibiotics, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815929/9781555812379_Chap30-1.gif /docserver/preview/fulltext/10.1128/9781555815929/9781555812379_Chap30-2.gif

Abstract:

Peptide antibiotics differ structurally from conventional peptides in that they are cyclic and contain ester bonds and D-configured or unusual amino acids, unusual nuclei (such as saturated or unsaturated fatty acids), and heterocycles or amino or nonamino sugars. The peptide antibiotics can be divided into seven groups: I, linear peptides; II, cyclic peptides; III, glycopeptides; IV, lipoglycopeptides; V, lipopeptides; VI, thiazolopeptides; and VII, thiopeptides and chromopeptides. Polypeptide antibiotics induced during an infection in insects, such as cecropins or attacins, have been described in this class. It is highly effective against gram-negative bacilli like and , whereas gram-positive cocci, such as , are poorly inhibited. The majority of peptides of natural or synthetic origin cannot be used as therapeutic agents, as they are unstable in biological liquids, they are toxic, their antibacterial spectrum is limited, and they manifest only weak activity. The cyclic peptides are among the best-studied peptide antibiotics. The majority of molecules have two chlorine atoms on the triphenyl ether nucleus. The teichomycins are lipoglycopeptide antibiotics obtained from fermentation of an actinomycete, . In order of inhibitory activity, the pneumocandins may be classified as follows: B > A, A > A, B > C. The bacitracin group consists of hexapeptide antibiotics with a substituted thiazolidine nucleus.

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30

Key Concept Ranking

Antibacterial Agents
0.9760134
Basic Amino Acids
0.68476814
Cyclic Amino Acids
0.68323624
Antimicrobial Peptides
0.64342815
Aromatic Amino Acids
0.63147175
Amino Acids
0.6156644
0.9760134
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 4
Figure 4

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 5
Figure 5

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 6
Figure 6

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 7
Figure 7

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 8
Figure 8

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 9
Figure 9

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 10
Figure 10

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 11
Figure 11

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 12
Figure 12

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 13
Figure 13

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 14
Figure 14

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 15
Figure 15

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 16
Figure 16

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 17
Figure 17

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 18
Figure 18

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 19
Figure 19

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 20
Figure 20

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 21
Figure 21

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 22
Figure 22

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 23
Figure 23

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 24
Figure 24

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 25
Figure 25

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 26
Figure 26

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 27
Figure 27

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 28
Figure 28

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 29
Figure 29

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 30
Figure 30

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 31
Figure 31

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 32
Figure 32

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 33
Figure 33

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 34
Figure 34

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 35
Figure 35

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 36
Figure 36

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 37
Figure 37

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 38
Figure 38

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 39
Figure 39

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 40
Figure 40

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Table 24
Table 24

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 41
Figure 41

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 42
Figure 42

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 43
Figure 43

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 44
Figure 44

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 45
Figure 45

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 46
Figure 46

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 47
Figure 47

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 48
Figure 48

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 49
Figure 49

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 50
Figure 50

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 51
Figure 51

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 52
Figure 52

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 53
Figure 53

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 54
Figure 54

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 55
Figure 55

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 56
Figure 56

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 57
Figure 57

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 58
Figure 58

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 59
Figure 59

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 60
Figure 60

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 61
Figure 61

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 62
Figure 62

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 63
Figure 63

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815929.ch30
1. Abdel-Ghany YS,, Ihnat MA,, Miller DD,, Kunin CM,, Tang HH, 1993, Structure-activity relationship of glycine-betaine analogs on osmotolerance of enteric bacteria, J Med Chem, 36, 784789.
2. Abe H,, Kushida K,, Shiobara Y,, Kodama M, 1988, The structures of sulfomycin I and berninamycin A, Tetrahedron Lett, 29, 14011404.
3. Allen JG,, Atherton FR,, Hall MJ,, Hassall CH,, Holmes SW,, Lambert RW,, Nisbet LJ,, Ringrose PS, 1978, Phosphonopeptides, a new class of synthetic antibacterial agents, Nature, 272, 5658.
4. Allen JG,, Atherton FR,, Hall MJ,, Hassall CH,, Holmes SW,, Lambert RW,, Nisbet LJ,, Ringrose PS, 1979a, Phosphonopeptides as antibacterial agents: alaphosphin and related phosphopeptides, Antimicrob Agents Chemother, 15, 684695.
5. Allen JG,, Havas L,, Leicht E,, Lenox-Smith L,, Nisbet LJ, 1979b, Phosphonopeptides as antibacterial agents: metabolism and pharmacokinetics of alafosfalin in animals and humans, Antimicrob Agents Chemother, 16, 306313.
6. Allen JG,, Lees LJ, 1980, Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans, Antimicrob Agents Chemother, 17, 973979.
7. Andres E,, Dimarcq JL, 2001, Les peptides antimicrobiens cationiques et leurs perspectives d’applications thérapeutiques, Antibiotique, 3, 201205.
8. Aronof GR,, Sloan RS,, Luft FC, 1988, LY 146032 kinetics in normal subjects and patients with renal insufficiency, 28th Intersci Conf Antimicrob Agents Chemother, 125.
9. Atherthon FR,, Hall MJ,, Hassall CH,, Lambert RW,, Ringrose PS, 1979, Phosphonopeptides as antibacterial agents, rationale, chemistry, and structure-activity relationships, Antimicrob Agents Chemother, 15, 677683.
10. Attendo-Genco C,, Maloy WL,, Kari UP,, Motley M, 2003, Antimicrobial activity of magainin analogues against anaerobic oral pathogens, Int J Antimicrob Agents, 21, 7578.
11. Balkovec JM, 1994, Lipopeptide antifungal agents, Expert Opin Investig Drugs, 3, 6582.
12. Bartoloni A,, Colao MG,, Orsi A,, Dei R,, Giganti E,, Parenti F, 1990, In vitro activity of vancomycin, teicoplanin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile, J Antimicrob Chemother, 26, 627633.
13. Berdy J, 1980, Thiazolyl peptides, p 389417. in Berdy J, ed, Handbook of Antibiotic Compounds, vol IV/1, CRC Press.
14. Bessalle R,, Haas H,, Goria A,, Shalit L,, Fridkin M, 1992, Augmentation of the antibacterial activity of magainin by positive-charge chain extension, Antimicrob Agents Chemother, 36, 313317.
15. Bloom H,, Katla T,, Nissen H,, Holo H, 2001, Characterization, production, and purification of carnocin H, a bacteriocin produced by Carnobacterium 377, Curr Microbiol, 43, 227231.
16. Boeck LD,, Berry DM,, Mertz FP,, Wetzel RW, 1992, A 10255, a complex of novel growth-promoting thiopeptide antibiotics produced by a strain of Streptomyces gardneri: taxonomy and fermentation studies, J Antibiot, 45, 12221230.
17. Borghi A,, Coronelli C,, Faniuolo L,, Allievi G,, Pallanza R,, Gallo GG, 1984, Teichomycins, news antibiotics from Actinoplanes teichomyceticus nov sp. IV. Separation and characterization of the components of teichomycin (teicoplanin), J Antibiot, 37, 615620.
18. Bourlioux P, 1989, Biochimie functionnelle des structures bactériennes, p 2251, in Le Minor L,, Veron M, ed, Bactériologie médicale, 2nd ed, Flammarion.
19. Cain BD,, Norton PJ,, Eubanks W,, Nick NS,, Allen CM, 1993, Amplification of the bcaA gene confers bacitracin resistance in Escherichia coli, J Bacteriol, 175, 37843789.
20. Cheung KS,, Wasserman SA,, Dudek E,, Lerner SA,, Johsnton M, 1983, Chloroalanyl and propargylglycine dipeptides: suicide substrate containing antibacterials, J Med Chem, 26, 17331741.
21. Christensen B,, Fink J,, Merrifield RB,, Mauzerall D, 1988, Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes, Proc Natl Acad Sci USA, 85, 50725076.
22. Clark BFC,, Kjeldgaard M,, Lacour TFM,, Thirup S,, Nyoborg J, 1990, Structural determination of the functional sites of E. coli elongation factor Tu, Biochim Biophys Acta, 1050, 203208.
23. Cole A,, Deronich MRO,, Legarda D,, Connell N,, Diamond G, 2000, Characterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activity, Antimicrob Agents Chemother, 44, 20392045.
24. Counter FT,, Ensminger PW,, Wu CEY, 1989, A10255, a new thiopeptide antibiotic complex, produced by Streptomyces gardneri. 3. Microbiological evaluation, 29th Intersci Conf Antimicrob Agents Chemother, abstract 411.
25. Cristofaro MF,, Beauregard DA,, Yan H,, Osbrn NJ,, Williams DH, 1995, Cooperativity between non-polar and ionic forces in the binding of bacteria cell wall analogues by vancomycin in aqueous solution, J Antibiot, 48, 805810.
26. Curran WV,, Leese RA,, Borders DB,, Koontz MZ,, Liu H,, Simon RJ, 2002, Semisynthetic approaches to laspartomycin analogs, 42nd Intersci Conf Antimicrob Agents Chemother, abstract 1175.
27. Dabard J,, Bridonneau C,, Phillipe C,, Anglade P,, Molle D,, Nardi M,, Ladiré M,, Girardin H,, Marcille F,, Gomez A,, Fons M, 2001, Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces, Appl Environ Microbiol, 67, 41114118.
28. Egawa Y,, Umino K,, Tamura Y,, Shimizu M,, Kaneko K,, Sukurazawa M,, Awataguchi S,, Okuda T, 1969, Sulfomycins, a series of new sulfur-containing antibiotics. I. Isolation, purification and properties, J Antibiot, 22, 1217.
29. Fernandez-Lopez S,, Kim HS,, Choi EC,, Delgado M,, Granja JR,, Khasanov A,, Kraehenbuehl K,, Long G,, Weinberger DA,, Wilcoxen KM,, Ghadiri MR, 2001, Antibacterial agents based on the cyclic D, l-α peptide architecture, Nature, 412, 452456.
30. Fowden L,, Lewis D,, Tristam H, 1967, Toxic amino acids: their action as antimetabolites, Adv Enzymol, 1967, 89.
31. Francis J,, Webster H,, Newsom SWB, 1990, In vitro activity of ramoplanin on Staphylococci, Drugs Exptl Clin Res, 16, 457460.
32. Fujii CA,, Boggs A,, Stapp J,, Burns JL,, Redman R, 2001, In vitro activity of isogenan (IB-367) against bacterial isolates obtained from cystic fibrosis enrolled in a phase I trial, 41st Intersci Conf Antimicrob Agents Chemother.
33. Ganguli BN,, Chatterjee S,, Jani GP,, Pai GP,, Chatterjee DK,, Blumbach J,, Kogler H,, Fehlhaber HW,, Teetz V,, Klesel N,, Seibert G, 1989, Mersacidin, a novel peptide antibiotic: discovery and antimicrobial evaluation, 29th Intersci Conf Antimicrob Agents Chemother, abstract 478.
34. Goldstein BP,, Berti M,, Ripamonti F,, Candiani GP,, Romano G,, Bellini S,, Denaro M, 1990, Antimicrobial activity of GE 2270A, a new peptide antibiotic which inhibits protein synthesis elongation factor EF-tu, 30th Intersci Conf Antimicrob Agents Chemother, abstract 800.
35. Goldstein BP,, Berti M,, Ripamonti F,, Resconi A,, Scotti R,, Denaro M, 1993, In vitro antimicrobial activity of a new antibiotic, MDL 62879 (GE 2270 A), Antimicrob Agents Chemother, 37, 741745.
36. Goldstein BP,, Candiani G,, Arain TM,, Romano G,, Ciciliato I,, Berti M,, Abbondi M,, et al, 1995, Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic, Antimicrob Agents Chemother, 39, 15801588.
37. Gordee R,, Farmer J,, Zeckner D, 1992, LY 295337, a novel cyclic depsipeptide antifungal antibiotic. I. In vitro antifungal activity, 32nd Intersci Conf Antimicrob Agents Chemother, abstract 496.
38. Greenlee WJ,, Springer JP,, Patchett AA, 1989, Synthesis of an analogue of Tabtoxinine as a potential inhibitor of d-alanine-d-alanine ligase (ADP forming), J Med Chem, 32, 165170.
39. Hancock REW, 1998, The therapeutic potential of cationic peptides, Expert Opin Investig Drugs, 7, 167174.
40. Haneishi T,, Nakajima M,, Shiraishi A,, Katayama T,, et al, 1985, A new antimycobacterial antibiotic, dihydromycoplanecin A. I. In vitro activities and pharmacokinetics in mice and dogs, Recent Adv Chemother, 3, 25442545.
41. Heinemann B,, Kaplan MA,, Muir RD,, Hooper IR, 1953, Amphomycin—a new antibiotic, Antib Chemother, 3, 239.
42. Hernanz A, 1990, Characterization and distribution of bombesin-like peptide in the rat brain and gastrointestinal tract, Biochem Cell Biol, 68, 11421145.
43. Hill J,, Siedlecki J,, Parr I,, Morytko M,, Yu X,, Zhang Y,, Silverman J,, Controneo Y,, Laganas V,, Li T,, Lai J-J,, Keith D,, Shimer G,, Finn J, 2003, Synthesis and biological activity of N-acylated ornithine analogues of daptomycin, Bioorg Med Chem Lett, 13, 41874191.
44. Hiradate S,, Yoshida S,, Sugie H,, Yada H,, Fujii Y, 2002, Mulberry anthracnose antagonists (iturins) produced by Bacillus amyloliquefaciens RC-2, Phytochem, 61, 693698.
45. Hirth GG,, Veron M,, Villar-Parasi C,, Hurion N,, Cohen GN, 1975, The threonine-sensitive homoserine dehydrogenase and aspartokinase activities of Escherichia coli K-12, Eur J Biochem, 50, 425.
46. Janiszewska J,, Swieton J,, Lipkowski AW,, Urbanczyk-Lipkowska Z, 2003, Low molecular mass peptide dendrimers that express antimicrobial properties, Bioorg Med Chem Lett, 13, 37113713.
47. Jimenez-Mejias ME,, Becerril B,, Marquez-Rivas FJ,, Pichardo C,, Cuberos L,, Pachon J, 2000, Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colisitin sulfomethane sodium, Eur J Clin Microbiol Infect Dis, 19, 970971.
48. Judice JK,, Pace JL, 2003, Semisynthetic glycopeptide antibacterials, Bioorg Med Chem Lett, 13, 41654168.
49. Jung G, 1991, Lantibiotics—ribosomally synthesized biologically active polypeptides containing sulfide bridge and α,β-didehydroamino acids, Angew Chem, 30, 10511192.
50. Kellner R,, Jung G,, Horner T,, Zahner H,, Schnell N,, Entian KD,, Götz F, 1988, Gallidermin, a new lanthionine containing polypep-tide antibiotic, Eur J Biochem, 177, 5359.
51. Kenny MT,, Brackman MA,, Dulworth JK, 1995, In vitro activity of the semisynthetic glycopeptide amide MDL 63,246, Antimicrob Agents Chemother, 39, 15891590.
52. King A,, Bethune L,, Phillips L, 1993, In vitro activity of MDL 62879 (GE 2270 A) against aerobic gram-positive and anaerobic bacteria, Antimicrob Agents Chemother, 37, 746749.
53. Komatsu Y,, Miwa H,, Matsumoto K, et al, 1991, S-3662, a new glycopeptide antibiotic for parenteral use, laboratory evaluation, 31st Intersci Conf Antimicrob Agents Chemother, abstract 413.
54. Landini P,, Bandera M,, Soffientini A,, Goldstein BP, 1993, Sensitivity of elongation factor Tu (RfTu) from different bacterial species to the antibiotics efrotomycin, pulvomycin and MDL 62,879, J Gen Microbiol, 139, 769774.
55. Lee JY,, Boman A,, Chuanxin S,, Anderson M,, Jornvall H,, Mutt V,, Boman H, 1989, Antibacterial peptides from pig intestine, isolation of a mammalian cecropin, Proc Natl Acad Sci USA, 86, 91599162.
56. Lee MD,, Roll DM,, Williams F,, Ashcroft J,, Siegel M,, Chang CC,, Manning JK,, Pinho F,, Borders DB, 1992, LL-A0341 antibiotics. I. Isolation and chemical structure of LL-A0341 β, γ1, γ2, δ1, and α, 32nd Intersci Conf Antimicrob Agents Chemother, abstract 508.
57. Lehrer RI, 1993, Defensins, antimicrobial and cytotoxic peptides of mammalian cells, Annu Rev Immunol, 11, 105128.
58. Loesch WJ, 1994, Normal microflora of the human body, p 120128, in Nissengard RJ,, Neuman MG, ed, Oral Microbiology and Immunology, The WB Saunders Co, Philadelphia, Pa.
59. Malabarba A,, Ciabatti R,, Scotti R,, Goldstein BP,, Ferrari P,, Kurz M,, Andreini BP,, Denaro M, 1995, New semisynthetic glycopeptide MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant Van A enterococci, J Antibiot, 48, 869883.
60. Malabarba A,, Pallanza R,, Berti M,, Cavalleri B, 1990, Synthesis and biological activity of some amide derivatives of the lantibiotic actagardin, J Antibiot, 43, 10891100.
61. Malkoski M,, Dasper S,, O’Brien-Simpson NM,, Talbo GH,, Macris M,, Cross KJ,, Reynolds EC, 2001, Kappacin, a novel antibacterial peptide from bovine milk, Antimicrob Agents Chemother, 45, 23092315.
62. Matsumoto M,, Kawamura Y,, Yassuda Y,, Tanimoto T,, Matsumoto K,, Yoshida T,, Shoji JI, 1989, Isolation and characterization of thioxamycin, J Antibiot, 42, 14651469.
63. Michel KH,, Hoehn MM,, Boeck LD,, Martin JW,, Abbott MA,, Godfrey OW,, Meitz FP, 1989, A10255, a new thiopeptide complex. I. Discovery, fermentation, isolation and characterization, 29th Intersci Conf Antimicrob Agents Chemother, abstract 409.
64. Mosca DA,, Hurst MA,, So W,, Viajar BSC,, Fujii CA,, Falla TJ, 2000, IB-367, a protegrin peptide with in vitro and in vivo activities against microflora associated with oral mucositis, Antimicrob Agents Chemother, 44, 18031808.
65. Nagarajan R,, Schabel AA,, Occolowitz JL,, Counter FT,, Ott JL, 1988a, Synthesis and antibacterial activity of N-acyl vancomycins, J Antibiot, 42, 14301438.
66. Nagarajan R,, Schabel AA,, Occolowitz JL,, Counter FT,, Ott JL,, Felty-Duckworth AM, 1988b, Synthesis and antibacterial evaluation of N-alkyl vancomycins, J Antibiot, 42, 6372.
67. Navon-Venezia S,, Fedor R,, Gaidukov I,, Carmeli Y,, Mor A, 2001, Antibacterial dermaseptin S4 derivatives, 41st Intersci Conf Antimicrob Agents Chemother, abstract F-348.
68. Niu WW,, Neu HC, 1991, Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin, Antimicrob Agents Chemother, 35, 9981000.
69. Oki T,, Hirano M,, Tomatsu K,, Numata KI,, Kamei H, 1989, Cispentacin, a new antifungal antibiotic. II. In vitro and in vivo antifungal activities, J Antibiot, 42, 17561762.
70. Pace JL,, Krause K,, Johnston D,, Debabov D,, Wu T,, Farrington L,, Lane C,, Higgins DL,, Christensen B,, Judice JK,, Koniga K, 2003, In vitro activity of TD 6424 against Staphylococccus aureus, Antimicrob Agents Chemother, 47, 36023604.
71. Parenti F,, Cavalleri B, 1990, Novel glycopeptide antibiotics of the dalbaheptide group, Drugs Future, 15, 5772.
72. Parenti F,, Ciabatti R,, Cavalleri B,, Kettenring J, 1990, Ramoplanin, a review of its discovery and its chemistry, Drugs Exp Clin Res, 16, 451455.
73. Patchett AA,, Taub P,, Weissberger B,, Valiant ME,, Gadebusch H,, Thornberry NA,, Bull HG, 1988, Antibacterial activities of fluorovinyl- and chlorovinylglycine and several derived dipeptides, Antimicrob Agents Chemother, 32, 319333.
74. Patrzykat A,, Gallant JW,, Seo J-K,, Pytyck J,, Douglas SE, 2003, Novel antimicrobial peptides derived from flatfish genes, Antimicrob Agents Chemother, 47, 24642470.
75. Petersen PJ,, Weiss WJ,, Jacobus NV,, Testa RT, 1992, Comparative in vitro and in vivo activity of LL-A0341 β1, a cyclic depsipeptide antibiotic, 32nd Intersci Conf Antimicrob Agents Chemother, abstract 502.
76. Pfeiffer RR, 1981, Structural features of vancomycin, Rev Infect Dis, 3, suppl, S205–S209.
77. Porse BT,, Leviev J,, Mankin A,, Garrett RA, 1998, The antibiotic thiostrepton inhibits a functional transition within protein 11α at the ribosome GTPase center, J Mol Biol, 276, 391404.
78. Raj PA,, Deutino AR, 2002, Current status of defensins and their role in innate and adaptative immunity, FEMS Microbiol Lett, 206, 918.
79. Raju B,, Mortell K,, O’Dowd H,, Gao H,, Kumar AS,, Gomez M,, Hackbarth C,, Wu C,, Wang W,, Yuan Z,, White R,, Trias J,, Patel DW, 2002, N- and C-terminal modifications of negamycin, 42nd Intersci Conf Antimicrob Agents Chemother, abstract F-1685.
80. Rasch M,, Knochel S, 1998, Variations in tolerance of Listeria monocytogenes to nisin, pediocin PA-1 and bavaricin A, Lett Appl Microbiol, 27, 275278.
81. Regueiro-Ren A,, Naidu BN,, Zheng X,, Hudyma T,, Connolly TP,, Matiskella J,, Zhang Y,, Kim OK,, Sorensen ME,, Pucci M,, Clark J,, Bronson JJ,, Ueda Y, 2004, Novel semisynthetic nocathiacin antibiotics: synthesis and antibacterial activity of bis- and mono-O-alkylated derivatives, Bioorg Med Chem Lett, 14, 171175.
82. Ringrose PS, 1980, Peptides as antimicrobial agents, p 641-692, in Payne JW, ed, Microorganisms and Nitrogen Source, John Wiley and Sons Ltd.
83. Rolston KVI,, Nguyen H,, Messer M, 1990, In vitro activity of LY 264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer, Antimicrob Agents Chemother, 34, 21372141.
84. Ryser ET,, Maisnier-Patin S,, Gratadoux JJ,, Richard J, 1994, Isolation and identification of cheese smear bacteria inhibitory to Listeria spp., Int J Food Microbiol, 21, 237246.
85. Sajjan US,, Tran LT,, Sole N,, Rovaldi C,, Akiyama A,, Friden PM,, Forstner JF,, Rothstein DM, 2001, P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients, Antimicrob Agents Chemother, 45, 34373444.
86. Samyn B,, Martinez-Bueno M,, Devreese B,, Maquela M,, Galvez A,, Valdivia E,, Coyette J,, van Beenmen J, 1999, The cyclic structure of the enterococcal peptide antibiotic AS-48, FEBS Lett, 352, 8790.
87. Sanchez ML,, Wenzel RP,, Jones RN, 1992, In vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic, Antimicrob Agents Chemother, 36, 873875.
88. Sandage B,, Cooper G,, Najarian N,, Lowther J,, Girard AM, 2005, Pharmacokinetics and fungicidal activity of aminocandin (HMR 3270), a novel echinocandin, in healthy volunteers, 15th Eur Cong of Chemother, Microbiol and Infect Dis, Copenhagen.
89. Schittek B,, Hipfel R,, Sauer B,, Bauer J,, Kalbacher H,, Stevanovic S,, Schirle M,, Schroeder K,, Blin N,, Meier F,, Rassner G,, Garbe C, 2001, Dermacidin: a novel human antibiotic peptide secreted by sweat glands, Nat Immunol, 2, 11331137.
90. Schröder JM, 1999, Epithelial peptide antibiotics, Biochem Pharmacol, 57, 121134.
91. Schwartz SN,, Warren MR,, Barkley FA,, Landis L, 1959, Microbiological and pharmacological studies of colistin sulfate and sodium colistin methane sulfonate, Antib Annu 1959, p 41.
92. Selva E,, Beretta G,, Montanini N,, Gastaido L,, Lorenzetti R,, Landini P,, Montanaro L,, Parmoggiani A,, Goldstein BP,, Denaro M, 1990, Antibiotic GE 2270 A, a novel inhibitor of bacterial protein synthesis. I. Discovery, isolation, characterization, 30th Intersci Conf Antimicrob Agents Chemother, abstract 798.
93. Selva E,, Beretta G,, Montanini N,, Saddler GS,, et al, 1991, Antibiotic GE 2270 A, a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization, J Antibiot, 44, 693701.
94. Selva E,, Goldstein BP,, Ferrari P,, Pallanza R,, Riva E,, Berti M,, Borghi A,, et al, 1988, A 40926 aglycone and pseudoaglycones, preparation and biological activity, J Antibiot, 41, 12431252.
95. Shimanaka K,, Iinuma H,, Hamada M,, Ikeno S,, Tsuchiya S,, Arita M,, Hori M, 1995, Novel antibiotics, amythiamicins. IV. A mutation in the elongation factor Tu gene in a resistant mutant of Bacillus subtilis, J Antibiot, 48, 182184.
96. Shimanaka K,, Takahashi Y,, Iinuma H,, Naganawa H,, Takeuchi T, 1994a, Novel antibiotics, amythiamicins. II. Structure elucidation of amythiamicin D, J Antibiot, 47, 11451152.
97. Shimanaka K,, Takahashi Y,, Iinumura H,, Naganawa H,, Takeuchi T, 1994b, Novel antibiotics, amythiamicins. III. Structure elucidation of amythiamicin A, B, C, J Antibiot, 47, 11531159.
98. Shinagawa S,, Kasahara F,, Wada Y,, Harada S,, Asai M, 1984, Structures of bulgecins, bacterial metabolites with bulge-inducing activity, Tetrahedron, 40, 34653470.
99. Siedlecki J,, Hill J,, Parr I,, Yu X,, Moryto M,, Zhang Y,, Silverman J,, Controneo Y,, Leganas V,, Li T,, Li J,, Keith D,, Shimer G,, Finn J, 2003, Array synthesis of novel lipodepsipeptide, Bioorg Med Chem Lett, 13, 42454249.
100. Stella S,, Montanini N,, Le Monnier F,, Ferrari P,, Colombo L,, Landini P,, Ciciliato I,, Goldstein BP,, Selva E,, Denaro M, 1995, Antibiotic GE 37468 A, a new inhibitor of bacterial synthesis. I. Isolation and characterization, J Antibiot, 48, 780786.
101. Sugawara K,, Konishi M,, Kawaguchi H, 1984, BMY 28160, a new peptide antibiotic, J Antibiot, 37, 12571259.
102. Takahashi H,, Kondo E,, Koseki Y,, Haneishi T,, Arai M,, Tokunoga T, 1995, A new antimycobacterial antibiotic, dihydromycoplanecin A. II. In vivo activities of dihydromycoplanecin A in combination with isoniazid on the experimental mycobacteriosis in mice, Recent Adv Chemother 3, 25462547.
103. Tavecchia P,, Lociuro S,, Ripamonti F,, Berti M,, Bellini S,, Selva E,, Ciabatti R,, Goldenstein BP,, Denaro M, 1992, Synthesis and antibacterial activity of MDL 63,908, a water-soluble analog of MDL 62,879 (GE 2270 A), 32nd Intersci Conf Antimicrob Agents Chemother, abstract 1354.
104. Toriya M,, Shizuki Ishiquro M,, Ogawa K, 2004, In vitro and in vivo antibacterial activity of a novel lantibiotic API 17444, 44th Intersci Conf Antimicrob Agents Chemother, abstract F-1932.
105. Tsuda H,, Yamashita Y,, Shibata Y,, Nakawa Y,, Koga T, 2002, Genes involved in bacitracin resistance in Streptococcus mutans, Antimicrob Agents Chemother, 46, 37563764.
106. Umehara K,, Ezaki M,, Iwami M,, Yamashita M,, et al, 1984, Novel peptide antibiotics, WS43708A and B, 24th Intersci Conf Antimicrob Agents Chemother.
107. van Schaik W,, Gahan CG,, Hill C, 1999, Acid-adapted Listeria monocytogenes displays enhanced tolerance against the lantibiotics nisin and lacticin 3147, J Food Protect, 62, 536539.
108. Wade D,, Andreu D,, Mitchell SA,, Silveira AMY,, Boman A,, Boman HG,, Merrifield RB, 1992, Antibacterial peptides designed as analogs or hybrids of cecropins and mellitin, Int J Peptide Protein Res, 40, 429436.
109. Walsh CT, 1989, Enzymes in the d-alanine branch of bacterial cell wall peptidoglycan assembly, J Biol Chem, 264, 23932396.
110. Wang CLJ, 1992, Antifungal agents: recent patent activity, Curr Opin Therap Patent, 247252.
111. Williams AH,, Grüneberg RN, 1984, Teicoplanin, J Antimicrob Chemother 14, 441.
112. Woodworth JR,, Nyhart EH Jr,, Brier GL,, Wolny JD,, Black HR, 1992, Single-dose pharmacokinetics and antibacterial activity for daptomycin, a new lipopeptide antibiotic, in healthy volunteers, Antimicrob Agents Chemother, 36, 318325.
113. Yamaguchi H,, Uchida K,, Hiratani T,, Nagase T,, Watanabe N,, Omura S, 1989, RI-331, a new antifungal antibiotic, Ann N Y Acad Sci, 544, 188189.
114. Yao JDC,, Elioupoulos GM,, Moellering RC Jr, 1989, In vitro activity of SKF 104662, a new glycopeptide antibiotic, Antimicrob Agents Chemother, 33, 965967.
115. Zasloff M, 1987, Magainins, a class of antimicrobial peptides from Xenopus skin, isolation, characterization of two active forms and partial C-DNA sequence and precursors, Proc Natl Acad Sci USA, 84, 54495453.
116. Zboinska E,, Lejczak B,, Kafarski P, 1993, Antibacterial activity of phosphonopeptides based on 4-amino-4-phosphono butyric acid, FEMS Microbiol Lett, 108, 225230.

Tables

Generic image for table
Table 1

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 2

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 3

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 4

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 5

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 6

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 7

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 8

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 9

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 10

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 11

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 12

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 13

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 14

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 15

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 16

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 17

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 18

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 19

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 20

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 21

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 22

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 23

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 25

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 26

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 27

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 28

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 29

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 30

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 31

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 32

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 33

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 34

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 35

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 36

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 37

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 38

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 39

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 40

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 41

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 42

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 43

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 44

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 45

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30
Generic image for table
Table 46

Citation: Bryskier A. 2005. Peptide Antibiotics, p 826-879. In Bryskier, M.D. A (ed), Antimicrobial Agents. ASM Press, Washington, DC. doi: 10.1128/9781555815929.ch30

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error